Sign In
Buy PRNB
$100.05
+0 (+0%)
At Close: May 27, 2022
Invesco Ltd. Sells 8,388 Shares of Principia Biopharma Inc (NASDAQ:PRNB)
05:58am, Monday, 20'th Jul 2020
Invesco Ltd. lessened its stake in Principia Biopharma Inc (NASDAQ:PRNB) by 40.0% during the 1st quarter, Holdings Channel.com reports. The firm owned 12,605 shares of the company’s stock after sell
Why Principia Could Be the Next Target of Sanofi's Makeover
03:11pm, Sunday, 19'th Jul 2020
Buyout rumors have spurred a sharp increase in the small biotech’s shares Continue reading...
Stocks To Watch: Vaccine Players, Earnings Blitz And Fiscal Debate
08:24am, Saturday, 18'th Jul 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Principia Sanofi Rumors, And Other News: The Good, Bad And Ugly Of Biopharma
12:51pm, Friday, 17'th Jul 2020
Principia up on Sanofi interest rumors. Qiagen N.V.
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 16)
AC Immune SA (NASDAQ: ACIU...
Principia Biopharma Soars as Sanofi Is Said to Seek Deals
07:52pm, Thursday, 16'th Jul 2020
Sanofi is reportedly looking at potential acquisitions of U.S. biotechs. Principia Biopharma shares jumped on the report.
Sanofi Considers U.S. Biotech Targets Including Principia
06:15pm, Thursday, 16'th Jul 2020
(Bloomberg) -- Sanofi is studying potential acquisitions of U.S. biotechnology companies including Principia Biopharma Inc. as it seeks innovative treatments for clinical areas including multiple scle
Principia Biopharma (PRNB) Jumps: Stock Rises 6.8%
12:42pm, Thursday, 16'th Jul 2020
Principia Biopharma (PRNB) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Principal Financial Group Inc. Makes New Investment in Principia Biopharma Inc (NASDAQ:PRNB)
05:58am, Wednesday, 24'th Jun 2020
Principal Financial Group Inc. acquired a new position in shares of Principia Biopharma Inc (NASDAQ:PRNB) during the 1st quarter, according to its most recent 13F filing with the SEC. The fund acquire
Principia Announces First Patient Enrolled in Sanofi’s Phase 3 Trial of SAR442168 in Relapsing Multiple Sclerosis
05:15am, Tuesday, 23'rd Jun 2020
Upon dosing, Principia will be entitled to a $50 million milestone payment. SAR442168, discovered by Principia and formerly known as PRN2246, is a Bruton’s tyrosine kinase (BTK) inhibitor that cros
Deutsche Bank AG Sells 31,222 Shares of Principia Biopharma Inc (NASDAQ:PRNB)
06:57am, Saturday, 20'th Jun 2020
Deutsche Bank AG trimmed its holdings in shares of Principia Biopharma Inc (NASDAQ:PRNB) by 23.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities
Principia Biopharma Inc (NASDAQ:PRNB) Insider Sells $334,368.00 in Stock
05:40am, Saturday, 20'th Jun 2020
Principia Biopharma Inc (NASDAQ:PRNB) insider Stefani Wolff sold 5,504 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $6
Hedge Funds Have Never Been This Bullish On Principia Biopharma Inc. (PRNB)
07:07pm, Thursday, 18'th Jun 2020
In this article you are going to find out whether hedge funds think Principia Biopharma Inc. (NASDAQ:PRNB) is a good investment right now. We like to check what the smart money thinks first before doi
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Global Blood Therapeutics (GBT –
Principia Announces Positive Data from its Phase 2 Part B Trial in Pemphigus
08:05pm, Friday, 12'th Jun 2020
The full data set was presented as part of the virtual Late-Breaker session of the American Academy of Dermatology. “The significance of this Phase 2 Part B trial is that rilzabrutinib, a reversibl
